Four out of five pregnant women in Ireland are iron deficient by their third trimester, a University College Cork (UCC) study reveals.
Novo and Viatris settle Ozempic patent suit as generic entry date remains unknown
Novo Nordisk and Mylan Pharmaceuticals, now part of Viatris, have settled their patent dispute over Novo’s blockbuster diabetes drug Ozempic. The Danish company declined to